Search - tctmd.com

Displaying 381 - 400 of 870

Sort: Relevancy | Date

Presentation TCT Abstracts Posters 2018

Admission for Decompensated Congestive Heart Failure Within 30 days Prior to Transcatheter Aortic Valve Replacement is Associated with High Rates of Mortality and Readmission Within

Presenter: Tariq Bhat

September 25, 2018

Presentation TCT 2018

To Cath or Not to Cath in OHCA: Data and Decision-Making Criteria

Presenter: Navin K. Kapur, Duane S. Pinto, Christian M. Spaulding

September 24, 2018

Presentation TCT 2018

Using Hemodynamics to Guide Decision-Making in Cardiogenic Shock

Presenter: Vladimir Dzavik, Richard Smalling, Salvatore F Mannino

September 24, 2018

Presentation TCT 2018

Managing a Busy LAA Closure Program: Patient Selection, Education, Consent, Screening, and Periprocedural Care

Presenter: James B. Hermiller Jr, David Hildick-Smith, George S. Hanzel

September 24, 2018

Presentation TCT 2018

Adjunctive Pharmacology Following LAA Closure in Anticoagulant Indicated and Contraindicated Patients

Presenter: James B. Hermiller Jr, David Hildick-Smith, Martin W. Bergmann

September 24, 2018

Presentation TCT 2018

Essential of Pre-procedural Imaging and Intra-procedural Guidance

Presenter: James B. Hermiller Jr, David Hildick-Smith, Jacqueline Saw

September 24, 2018

Presentation TCT 2018

Shared Decision-making in NVAF: The Patients Perspective

Presenter: James B. Hermiller Jr, David Hildick-Smith, Megan Coylewright

September 24, 2018

Presentation TCT 2018

Debate: Is LAA Closure a Valid Alternative for Patients with No or Mild Contraindications to Anticoagulants? Yes - LAA Closure Reduces Hemorrhagic Stroke and Mortality And Nearly Everyone Has a Reason Not to Take Oral Anticoagulants!

Presenter: James B. Hermiller Jr, David Hildick-Smith, David R. Holmes Jr.

September 24, 2018

Presentation TCT 2018

Debate: Is LAA Closure a Valid Alternative for Patients With No or Mild Contraindications to Anticoagulants? No NOACs Are Strongly Preferred to LAA Closure!

Presenter: James B. Hermiller Jr, David Hildick-Smith, Freek W.A. Verheugt

September 24, 2018

Presentation TCT 2018

Stroke Etiology, LAA Closure, and the Therapeutic Landscape: A Neurologists Perspective

Presenter: James B. Hermiller Jr, David Hildick-Smith, David E. Thaler

September 24, 2018

Presentation TCT 2018

FFRCT: Interactive Virtual Stenting and DECISION

Presenter: Pamela S. Douglas, Javier Escaned, Gregg W. Stone

September 24, 2018

Presentation TCT 2018

Data Analysis: The Big Three Trials - Decision CTO, EURO CTO, OPEN CTO

Presenter: John A. Spertus, Robert W. Yeh, Ajay J. Kirtane

September 24, 2018

Presentation TCT 2018

Decision-making and Treatment Selection for Patients With Complex Abdominal Aortic Aneurysms

Presenter: Robert A. Lookstein, Virendra I Patel

September 23, 2018

Presentation TCT 2018

Take-Home Messages: What Did We Learn From These Cases?

Presenter: Maurice Buchbinder, Vivek Y. Reddy

September 23, 2018